Skip to main content

Post-IPO Debt Pharmaceutical Companies

Explore 65 pharmaceutical startups that raised post-ipo debt funding. Access verified founder contact information and fundraising data.

Total Companies
65
Total Funding
$9.8B
Avg Funding
$393.7M
Cities
23

Export 65 Post-IPO Debt Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Cranford, United States
$25.0M
raised

Citius Oncology is a pharmaceutical company that provides the development and commercialization of innovative oncology therapies.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Irvine, United States
$150.0M
raised

Evolus medical aesthetics focused on providing physicians and their patients with expanded choices in aesthetic procedures and treatments.

May 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark
$291K
raised

CS MEDICA is a medical equipment manufacturing and distribution company focused on the treatment of autoimmune and stress-related disorders.

May 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Tampa, United States
$21.0M
raised

Wellgistics Health is a logistic company that focuses on streamlining healthcare technology and pharmaceutical from manufacturer to patient.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Nanaimo, Canada
$150.0M
raised

Tilray is a cannabis-lifestyle and consumer packaged goods company that offers cannabis, hemp-based foods, and craft beverages.

May 2023
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 65 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Saskatoon, Canada
$505K
raised

ZYUS is a biopharmaceutical company that offers patients cannabinoid and other phyto-therapeutic medical solutions.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Foster City, United States
$600.0M
raised

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$3.5M
raised

PharmaCielo is a global company privately held and headquartered in Canada.

May 2022
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Farmington Hills, United States
$35.0M
raised

Opus Genetics a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

San Juan, Puerto Rico
$22.5M
raised

Aspire Biopharma is a biotechnology company that develops nano technology drug formulation technology and medicinal products.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 65 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Pickering, Canada
$1.4M
raised

Ayurcann provides production services in extraction, processing, packaging, and distribution.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ørsta, Norway
$1.5M
raised

Arctic Bioscience is a biotech company that produces bioactive marine-based pharmaceutical and nutraceutical products and solutions.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Foster City, United States
$2.0M
raised

Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Calabasas, United States
$7.0M
raised

Turn Therapeutics is a pharmaceutical company that is dedicated to reducing the human and economic costs of infection and skin disease.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$605K
raised

Albert Labs is a pharmaceutical drug development company pursuing regulatory approval for active compounds to treat mental health.

Mar 2023
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 65 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
La Jolla, United States
$75.0M
raised

Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Mölndal, Sweden
$9.2M
raised

Cinclus Pharma is a research based biotech company.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Richmond, United States
$450.0M
raised

Indivior is a specialty pharmaceuticals business.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

North Chicago, United States
$8.0B
raised

AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics.

Feb 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$4.3M
raised

CannTrust is a producer of medical cannabis.

Feb 2022
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 65 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Oxford, United Kingdom
$714K
raised

OCT is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research.

Feb 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Dublin, Ireland
$125.0M
raised

Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.

Feb 2022
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Las Vegas, United States
$10.1M
raised

Flower One is a cannabis cultivator and producer.

Feb 2022
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Markham, Canada
$1.0M
raised

Canntab Therapeutics is a biopharmaceutical company that aims at manufacturing & distributing hard pill cannabinoid formulations.

Feb 2022
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Smiths Falls, Canada
$147.9M
raised

Canopy Growth is a cannabis consumer product company that manufactures medical cannabis to improve lives.

Jan 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Showing 26 to 50 of 65 companies

Ready to Connect with Post-IPO Debt Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 65 post-ipo debt pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

65 Pharmaceutical Post-IPO Debt Startups (September 2026) — Page 2 | VCBacked